Professor Girish M. Shah is Full Professor at Laval University (Faculty of Medicine) and a Senior Researcher at CHU de Quebec of Laval University Hospital Research Centre in Quebec City (QC), Canada (http://www.crchudequebec.ulaval.ca/recherche/chercheurs/girish-shah/). His work is focused on identifying novel roles of poly(ADP-ribose) polymerase-1 (PARP1) in cellular responses to DNA damage from DNA repair to cell death and cancer. His team has identified novel roles of PARP1 in the nucleotide excision repair pathway, and unique cleavage patterns of PARP1 in necrotic death. His team identified sub-clinical niacin deficiency in a subset of neuroendocrine tumor (NET) patients. He is currently working on discovering other roles of PARP1 in DNA repair and in improving peptide receptor radionuclide therapy of NET Cancer. He has been serving on the Board of Directors as well as on the Scientific and Medical Advisory Board of the Canadian Neuroendocrine Tumor Society (CNETS, https://cnets.ca/).
Professor Girish M. Shah is Full Professor at Laval University (Faculty of Medicine) and a Senior Researcher at CHU de Quebec of Laval University Hospital Research Centre in Quebec City (QC), Canada (http://www.crchudequebec.ulaval.ca/recherche/chercheurs/girish-shah/). His work is focused on identifying novel roles of poly(ADP-ribose) polymerase-1 (PARP1) in cellular responses to DNA damage from DNA repair to cell death and cancer. His team has identified novel roles of PARP1 in the nucleotide excision repair pathway, and unique cleavage patterns of PARP1 in necrotic death. His team identified sub-clinical niacin deficiency in a subset of neuroendocrine tumor (NET) patients. He is currently working on discovering other roles of PARP1 in DNA repair and in improving peptide receptor radionuclide therapy of NET Cancer. He has been serving on the Board of Directors as well as on the Scientific and Medical Advisory Board of the Canadian Neuroendocrine Tumor Society (CNETS, https://cnets.ca/).